Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Healthtrust
McKesson
Express Scripts
Boehringer Ingelheim
US Department of Justice
AstraZeneca
Julphar
Citi
McKinsey

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050514

« Back to Dashboard

NDA 050514 describes NATACYN, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from one supplier. Additional details are available on the NATACYN profile page.

The generic ingredient in NATACYN is natamycin. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the natamycin profile page.
Summary for 050514
Tradename:NATACYN
Applicant:Novartis Pharms Corp
Ingredient:natamycin
Patents:0
Therapeutic Class:Antifungals
Pharmacology for NDA: 050514
Ingredient-typePolyenes
Medical Subject Heading (MeSH) Categories for 050514
Suppliers and Packaging for NDA: 050514
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NATACYN natamycin SUSPENSION;OPHTHALMIC 050514 NDA Alcon Laboratories, Inc. 0065-0645 0065-0645-15 1 BOTTLE, GLASS in 1 CARTON (0065-0645-15) > 15 mL in 1 BOTTLE, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;OPHTHALMICStrength5%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Citi
Fuji
Boehringer Ingelheim
Julphar
US Department of Justice
Cantor Fitzgerald
Deloitte
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot